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Examining Acceptability of Self-Collection for Human 
Papillomavirus Testing Among Women and Healthcare Providers 
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In the Journal Of Women’s Health, Constance Mao et al. describe baseline findings from a 
randomized trial comparing self-collection for human papillomavirus (HPV) testing versus 
routine Papanicolaou (Pap) testing among women aged 21–65 years in Seattle, Washington.1 
They report on acceptability of self-collection for HPV testing among women as well as 
healthcare providers performing cervical cancer screening in the University of Washington 
medical clinics. This article highlights two key findings: First, self-collection for HPV 
testing was acceptable and preferred by women for cervical cancer screening in comparison 
with routine Pap-based testing. Second, most healthcare providers were willing to 
recommend self-collection for HPV testing, but reported that this was conditional on factors 
such as patients’ ability to collect adequate samples and test characteristics such as 
sensitivity, specificity, and cost-effectiveness. Health providers’ key concern about women 
performing HPV self-collection at home was the missed opportunity to address other health 
concerns during a screening visit.
Self-collection for HPV testing has been found to be widely acceptable among women 
worldwide. In the United States, studies have found self-collection for HPV testing to be 
acceptable among women from various cultural backgrounds and settings, including white 
women in rural Appalachian Kentucky, African American women in the Mississippi Delta, 
Somali immigrant women in Minnesota, Haitian immigrant women in Miami, and Hispanic 
women in California.2–6 In high-income countries with organized cervical cancer screening 
programs such as Sweden, the Netherlands, and Finland, self-collection for HPV testing has 
been found to be highly acceptable and increased screening uptake among women who do 
not respond to routine screening invitations.7–9 Self-collection for HPV testing has also been 
found to be highly acceptable in middle-income countries with organized screening 
programs such as Argentina, where research studies utilized existing community health 
worker networks for screening implementation.10 Also research studies in low-income 
countries such as India and Uganda have found high acceptability of self-collection among 
women.11 Although acceptability of self-collection has been studied, there is a need for 
broader examination into determinants of women’s attitudes or perceptions toward self-
collection for HPV testing such as their knowledge and understanding about HPV, and also 
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women’s compliance with the initial self-collection for HPV testing and any necessary 
follow-up procedures from a positive test result.
Women’s HPV knowledge has been found to be fairly low, even after brief education 
sessions,12 and their perceived self-efficacy in conducting self-collection procedures has 
been found to affect its acceptability in research studies. In the study by Mao et al., 56.7% of 
women who preferred a HPV test that used a physician-collected sample rather than a self-
collected sample reported to have more faith in the provider’s sample.1 Other studies 
conducted in Puerto Rico, the New York City area, and in rural China found that women 
preferred physician-collected to self-collected samples because they thought that they were 
more accurate.13–15 There is a need for implementation research on key messages and 
strategies to educate women about HPV testing, self-collection of samples, and HPV test 
results, specifically, messages that convey that a self-collected specimen can be as 
efficacious as a physician-collected specimen in detecting high-risk HPV.16 Messages that 
reduce anxiety, stress, or self-blame in women who have HPV-positive test results are also 
needed.17
A key question relating to the acceptability of self-collection for HPV testing and its 
effectiveness as a cervical cancer screening strategy is women’s compliance with the 
necessary follow-up procedures if they have HPV-positive test results. In countries such as 
the Netherlands that have organized screening programs, including a reminder/recall system 
to invite women for screening and databases to monitor screening procedures, compliance 
with follow-up procedures has been found to be higher in women offered self-collection than 
in women invited for conventional Pap-based screening.8 Compliance with follow-up 
procedures after self-collection for HPV testing could be difficult to promote or monitor 
outside an organized cervical cancer screening program. In a study in rural Appalachian 
Kentucky, patient navigation conducted by nurses was utilized to encourage women to 
receive Pap tests after self-collection for HPV testing, but only 7.5% did after 6 months.2 
The Centers for Disease Control and Prevention’s (CDC’s) National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP) is currently the only organized cervical 
cancer screening program for low-income, uninsured, and under insured women in the 
United States. The NBCCEDP uses a comprehensive reminder/recall approach to ensure 
follow-up that may serve as a good model for how to enhance compliance in women with 
HPV-positive results, if primary HPV testing and self-collection are recommended by U.S. 
organizations and implemented in the future. More research is needed to examine strategies 
to link women with HPV-positive results to clinical care and the appropriate number of 
clinic visits or patient encounters needed to complete cervical cancer screening, including 
the feasibility of screen-and-treat strategies.
This study by Mao et al. is one of the few studies that has examined attitudes toward self-
collection for HPV testing among healthcare providers. In this and two similar studies 
conducted in Ohio and Southwest Virginia, healthcare providers expressed concern about the 
efficacy of self-collection for HPV testing because they were uncertain about women’s 
ability to understand the self-collection instructions and collect adequate samples.18,19 As 
research on self-collection advances, there is a need to communicate key findings with 
healthcare providers; there is limited research on interventions to educate healthcare 
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providers about self-collection for HPV testing.20 Healthcare providers in Ohio were also 
wary of self-collection because HPV testing alone is not currently recommended as a 
screening strategy by some key organizations in the United States, although the U.S. Food 
and Drug Administration (FDA) approved the cobas HPV test for use in primary cervical 
cancer screening in women aged 25 years or older.21 Primary HPV testing and self-collected 
samples for cervical cancer screening are being reviewed as possible screening strategies by 
the U.S. Preventive Services Task Force.22 If cervical cancer screening recommendations 
change to include primary HPV testing and self-collection, more research would be needed 
to re-examine healthcare providers’ attitudes toward the use of self-collected samples for 
HPV testing and their willingness to provide the necessary follow-up procedures for women 
with HPV-positive results.
Interestingly, whereas healthcare providers in the study by Mao et al. were concerned about 
self-collection for HPV testing resulting in missed opportunities to interact with women, 
providers in a study conducted in Ohio thought that HPV self-collection may enable more 
women to come to health centers for follow-up of HPV test results.19 Currently, self-
collection for HPV testing is mostly being examined as a strategy to reach women who do 
not attend or have access to regular screening at health centers; the effect of HPV self-
collection on possibly reducing women’s clinic visit attendance or interactions with 
healthcare providers needs to be examined as implementation research progresses and HPV 
self-collection strategies and target populations are better defined.
Several research studies have shown that self-collection for HPV testing is generally 
acceptable among various populations of women. Implementation research on self-collection 
for HPV testing as a potential cervical cancer screening strategy requires a broader look at 
attitudes of women and their providers, perceptions or behaviors including compliance with 
follow-up procedures, and also methods to educate or communicate with women and 
healthcare providers about HPV and self-collection.
The content of this editorial does not necessarily represent the official position of the U.S. 
CDC.
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